Suchergebnisse - (Standardsuche:ritonavir)

PubPharm (1.538)

1

Real-world application of nirmatrelvir/ritonavir in hospitalized COVID-19 patients with onset of symptoms beyond 5 days : a comparative study

enthalten in: Infection | 2024

von Luo, W. | Li, K. | Dai, C. | +7

2

A combination of nirmatrelvir and ombitasvir boosts inhibition of SARS-CoV-2 replication

enthalten in: Antiviral research | 2024

von Moon, C. | Porges, E. | Roberts, A. | +1

3

Ritonavir : 25 Years' Experience of Concomitant Medication Management. A Narrative Review

enthalten in: Infectious diseases and therapy | 2024

von Quercia, R. | Di Perri, G. | Pein, C. | +4

4

Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance : a systematic literature review

enthalten in: Infection | 2024

von Drysdale, M. | Berktas, M. | Gibbons, D. | +3

5

Review : The Landscape of Antiviral Therapy for COVID-19 in the Era of Widespread Population Immunity and Omicron-Lineage Viruses

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Meyerowitz, E. | Li, Y.

6

Effectiveness of nirmatrelvir-ritonavir versus azvudine for adult inpatients with severe or critical COVID-19

enthalten in: BMJ open respiratory research | 2024

von Zhang, H. | Xiaojiao, T. | Chen, J. | +8

7

A Study to Learn About the Use of Paxlovid in Patients With COVID-19 in the Kingdom of Bahrain. : A Retrospective Observational Non-Interventional Study (NIS) to Assess Patient Characteristics and Healthcare Resource Use (HRU) Among COVID-19 Patients With or Without Nirmatrelvir/Ritonavir (PAXLOVID™) Treatment in the Kingdom of Bahrain.

enthalten in: ClinicalTrials.gov | 2024

8

The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants

enthalten in: Expert review of anti-infective therapy | 2024

von Hsu, C. | Hsu, W. | Shiau, B. | +6

9

Mild SARS-CoV-2 infection in vulnerable patients : implementation of a clinical pathway for early treatment

enthalten in: Enfermedades infecciosas y microbiologia clinica (English ed.) | 2024

von Pinargote-Celorio, H. | Otero-Rodríguez, S. | González-de-la-Aleja, P. | +11

10

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease : A PHASE 2/3, INTERVENTIONAL SAFETY, PHARMACOKINETICS, AND EFFICACY, OPEN-LABEL, MULTI-CENTER, SINGLE-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF-07321332 (NIRMATRELVIR)/RITONAVIR IN NONHOSPITALIZED SYMPTOMATIC PEDIATRIC PARTICIPANTS WITH COVID-19 WHO ARE AT RISK OF PROGRESSION TO SEVERE DISEASE

enthalten in: ClinicalTrials.gov | 2024

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[154]